Key facts
- This page summarizes ALEXANDRIA REAL ESTATE EQUITIES, INC.'s Form 4 filing for Applied Therapeutics, Inc. (APLT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Jun 2024, 18:45.
ALEXANDRIA REAL ESTATE EQUITIES, INC. - 04 Jun 2024 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- APLT
- Reported as of
- 04 Jun 2024
- Net transaction value
- -$1,267,500
- SEC form
- 4
- Accepted by SEC
- 06 Jun 2024, 18:45:54 UTC
- Prior SEC filing
- 01 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- ALEXANDRIA REAL ESTATE EQUITIES, INC., By: /s/ Marc E. Binda, Chief Financial Officer and Treasurer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
ALEXANDRIA REAL ESTATE EQUITIES, INC. filed Form 4 for Applied Therapeutics, Inc. (APLT) on 06 Jun 2024.
Change
- Previous filing in this sequence was filed on 01 Dec 2023.
- Current net transaction value: -$1,267,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APLT
transaction
Common Stock
Sale
- Transaction value
- $631,500
- Shares
- -150,000
- Change %
- -2.4%
- Price
- $4.21
- Shares after
- 6,005,077
- Date
- 04 Jun 2024
- Ownership
- By subsidiary
- Footnotes
- F1, F2
APLT
transaction
Common Stock
Sale
- Transaction value
- $636,000
- Shares
- -150,000
- Change %
- -2.5%
- Price
- $4.24
- Shares after
- 5,855,077
- Date
- 05 Jun 2024
- Ownership
- By subsidiary
- Footnotes
- F2, F3
APLT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 203,977
- Date
- 04 Jun 2024
- Ownership
- By subsidiary
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $4.12 to $4.32. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F2
These securities are held directly by Alexandria Venture Investments, LLC, an affiliate of Alexandria Equities No. 7, LLC ("AE7"), and a wholly owned subsidiary of Alexandria Real Estate Equities, Inc.
Footnote F3
The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $4.10 to $4.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F4
These securities are held directly by AE7, a wholly owned subsidiary of Alexandria Real Estate Equities, Inc.